Ipilimumab, with or without a gp100 peptide vaccine, as compared with gp100 alone, improved overall survival in patients with previously treated metastatic melanoma. Adverse eve...
Chimeric antigen receptor (CAR) T cell therapy is rapidly emerging as one of the most promising therapies for hematologic malignancies. Two CAR T products were recently approved...
American Cancer Society, National Institutes of Health, and Hope Foundation for Cancer Research.
Abstract Growing evidence suggests that breast cancer cells often reactivate latent developmental programs in order to efficiently execute the multi‐step process of tumorigenesi...